Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Improved treatment satisfaction in patients with type 2 diabetes treated with once-weekly semaglutide in the SUSTAIN trials
Semaglutide mimics the hormone GLP-1
Clinical studies have shown that patients taking tirzepatide can experience meaningful weight loss over time, especially with consistent use
Table of Contents Understanding Weight Loss Injections and Reproductive Health Weight loss injections, particularly GLP-1 receptor agonists such as semaglutide (Wegovy) and liraglutide (Saxenda), as well as tirzepatide (Mounjaro, a dual GIP/GLP-1 receptor agonist), have become increasingly prescribed for weight management in the UK
In summary, Ozempic, Wegovy, Rybelsus, and Mounjaro are newer-generation medications that help regulate appetite, blood sugar, and weight
